MESSAGE FROM SYMPOSIUM DIRECTOR

Dear Colleagues:


On behalf of the planning committee, I am excited to invite you to attend the 2022 UTHSC Surgical Oncology Cancer Symposium: Updates in the Multidisciplinary Management of Endocrine Tumors. As you can see from the attached brochure, we have an outstanding lineup of nationally recognized experts and local faculty.

This year’s symposium will take place on Saturday, October 1, in the newly renovated Mooney Building Library on the campus of the University of Tennessee Health Science Center (UTHSC).

This event is designed to be a high yield learning opportunity for healthcare providers involved in the evaluation and management of thyroid, parathyroid, and adrenal neoplasms with a mix of lectures and case-based panel discussions. Attendees can receive up to 5.75 AMA PRA Category 1 CME Credits™.

We look forward to your participation in this year’s symposium. Please see the attached brochure for registration details.


Sincerely –

Paxton Dickson, MD
Associate Professor
Department of Surgery
Division of Surgical Oncology
University of Tennessee Health Science Center

SYMPOSIUIM DESCRIPTION:

The University of Tennessee Health Science Center Division of Surgical Oncology is hosting a one-day symposium on the management of endocrine tumors. The purpose of this activity is to educate healthcare providers on up-to-date strategies for the evaluation and management of patients with thyroid, parathyroid, and adrenal neoplasms. The symposium will provide a unique opportunity for clinicians involved in the care of these patients to learn from and interact with leading national and local faculty to increase clinical knowledge, apply new data into practice, and ultimately improve patient outcomes.

OBJECTIVES

  • Understand the role of molecular diagnostics in the evaluation and management of thyroid nodules
  • Review the appropriate surgical management for well differentiated and medullary thyroid carcinoma
  • Understand systemic therapy options for patients with advanced thyroid cancer
  • Appreciate the radiographic evaluation of patients with primary hyperparathyroidism and the role of surgical therapy for these patients
  • Discuss the evaluation and management for patients with functional, non-functional, benign and malignant adrenal tumors.